These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28333397)

  • 21. Contrast venography vs. microwire assisted axillary venipuncture for cardiovascular implantable electronic device implantation.
    Beig JR; Ganai BA; Alai MS; Lone AA; Hafeez I; Dar MI; Tramboo NA; Rather HA
    Europace; 2018 Aug; 20(8):1318-1323. PubMed ID: 29036554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obese patients and mechanical circulatory support: weight loss, adverse events, and outcomes.
    Zahr F; Genovese E; Mathier M; Shullo M; Lockard K; Zomak R; McNamara D; Toyoda Y; Kormos RL; Teuteberg JJ
    Ann Thorac Surg; 2011 Oct; 92(4):1420-6. PubMed ID: 21958791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends of Sex Differences in Outcomes of Cardiac Electronic Device Implantations in the United States.
    Mohamed MO; Volgman AS; Contractor T; Sharma PS; Kwok CS; Rashid M; Martin GP; Barker D; Patwala A; Mamas MA
    Can J Cardiol; 2020 Jan; 36(1):69-78. PubMed ID: 31740167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased long-term mortality in patients with cardiovascular implantable electronic device infections.
    Rizwan Sohail M; Henrikson CA; Jo Braid-Forbes M; Forbes KF; Lerner DJ
    Pacing Clin Electrophysiol; 2015 Feb; 38(2):231-9. PubMed ID: 25243484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term outcomes following infection of cardiac implantable electronic devices: a prospective matched cohort study.
    Deharo JC; Quatre A; Mancini J; Khairy P; Le Dolley Y; Casalta JP; Peyrouse E; Prévôt S; Thuny F; Collart F; Raoult D; Habib G; Franceschi F
    Heart; 2012 May; 98(9):724-31. PubMed ID: 22523057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence, predictors, and outcomes associated with pneumothorax during cardiac electronic device implantation: A 16-year review in over 3.7 million patients.
    Ogunbayo GO; Charnigo R; Darrat Y; Morales G; Kotter J; Olorunfemi O; Elbadawi A; Sorrell VL; Smyth SS; Elayi CS
    Heart Rhythm; 2017 Dec; 14(12):1764-1770. PubMed ID: 28735733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retained cardiac implantable electronic device fragments are not associated with magnetic resonance imaging safety issues, morbidity, or mortality after orthotopic heart transplant.
    Austin CO; Landolfo K; Parikh PP; Patel PC; Venkatachalam KL; Kusumoto FM
    Am Heart J; 2017 Aug; 190():46-53. PubMed ID: 28760213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of cardiac resynchronization therapy-defibrillator implantation on the association between body mass index and prognosis in patients with heart failure.
    Yanagisawa S; Inden Y; Shimano M; Yoshida N; Ishikawa S; Kato H; Okumura S; Miyoshi-Fujii A; Nagao T; Yamamoto T; Mizutani Y; Ito T; Hirai M; Murohara T
    J Interv Card Electrophysiol; 2015 Sep; 43(3):269-77. PubMed ID: 26003807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of subcutaneous implantable cardioverter-defibrillator implantation in patients on hemodialysis.
    Koman E; Gupta A; Subzposh F; Saltzman H; Kutalek SP
    J Interv Card Electrophysiol; 2016 Mar; 45(2):219-23. PubMed ID: 26768264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular implantable electronic device implantation with uninterrupted dabigatran: comparison to uninterrupted warfarin.
    Jennings JM; Robichaux R; McElderry HT; Plumb VJ; Gunter A; Doppalapudi H; Osorio J; Yamada T; Kay GN
    J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1125-9. PubMed ID: 23889767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of device-related infection in 97 750 patients: clinical data from the complete Danish device-cohort (1982-2018).
    Olsen T; Jørgensen OD; Nielsen JC; Thøgersen AM; Philbert BT; Johansen JB
    Eur Heart J; 2019 Jun; 40(23):1862-1869. PubMed ID: 31155647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The obesity paradox in patients undergoing transcatheter aortic valve implantation.
    Konigstein M; Havakuk O; Arbel Y; Finkelstein A; Ben-Assa E; Leshem Rubinow E; Abramowitz Y; Keren G; Banai S
    Clin Cardiol; 2015 Feb; 38(2):76-81. PubMed ID: 25649013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of TTVI in Patients With Pacemaker or Defibrillator Leads: Data From the TriValve Registry.
    Taramasso M; Gavazzoni M; Pozzoli A; Alessandrini H; Latib A; Attinger-Toller A; Biasco L; Braun D; Brochet E; Connelly KA; de Bruijn S; Denti P; Deuschl F; Estevez-Louriero R; Fam N; Frerker C; Ho E; Juliard JM; Kaple R; Kodali S; Kreidel F; Kuck KH; Lauten A; Lurz J; Monivas V; Mehr M; Nazif T; Nickening G; Pedrazzini G; Praz F; Puri R; Rodés-Cabau J; Schäfer U; Schofer J; Sievert H; Tang GHL; Khattab AA; Thiele H; Unterhuber M; Vahanian A; Von Bardeleben RS; Webb JG; Weber M; Windecker S; Winkel M; Zuber M; Hausleiter J; Lurz P; Maisano F; Leon MB; Hahn RT
    JACC Cardiovasc Interv; 2020 Mar; 13(5):554-564. PubMed ID: 31954676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiotherapy-Induced Malfunction in Contemporary Cardiovascular Implantable Electronic Devices: Clinical Incidence and Predictors.
    Grant JD; Jensen GL; Tang C; Pollard JM; Kry SF; Krishnan S; Dougherty AH; Gomez DR; Rozner MA
    JAMA Oncol; 2015 Aug; 1(5):624-32. PubMed ID: 26181143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of In-Hospital Outcomes of Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Obese (Body Mass Index ≥ 30 Kg/M2) Patients.
    Ando T; Akintoye E; Trehan N; Telila T; Briasoulis A; Takagi H; Grines CL; Afonso L
    Am J Cardiol; 2017 Nov; 120(10):1858-1862. PubMed ID: 28860018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes of obese patients undergoing less invasive LVAD implantation.
    Voorhees HJ; Sorensen EN; Pasrija C; Kaczorowski D; Griffith BP; Kon ZN
    J Card Surg; 2019 Dec; 34(12):1465-1469. PubMed ID: 31692120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Durable left ventricular assist device implantation in extremely obese heart failure patients.
    Lee AY; Tecson KM; Lima B; Shaikh AF; Collier J; Still S; Baxter R; DiMaio JM; Felius J; Carey SA; Gonzalez-Stawinski GV; Nauret R; Wong M; Hall SA; Joseph SM
    Artif Organs; 2019 Mar; 43(3):234-241. PubMed ID: 30357882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrasound guided axillary vein access: An alternative approach to venous access for cardiac device implantation.
    Chandler JK; Apte N; Ranka S; Mohammed M; Noheria A; Emert M; Pimentel R; Dendi R; Reddy M; Sheldon SH
    J Cardiovasc Electrophysiol; 2021 Feb; 32(2):458-465. PubMed ID: 33337570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An 8-year single-centre experience of cardiac resynchronisation therapy: procedural success, early and late complications, and left ventricular lead performance.
    Ahsan SY; Saberwal B; Lambiase PD; Chaubey S; Segal OR; Gopalamurugan AB; McCready J; Rogers DP; Lowe MD; Chow AW
    Europace; 2013 May; 15(5):711-7. PubMed ID: 23315159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of same-day discharge versus overnight stay strategy following cardiac device implantations: a high-volume single-centre experience.
    Archontakis S; Oikonomou E; Sideris K; Laina A; Tirovola D; Paraskevopoulou D; Kostakis P; Doundoulakis I; Arsenos P; Ntalakouras I; Charitakis E; Gatzoulis K; Tsioufis K; Sideris S
    J Interv Card Electrophysiol; 2023 Mar; 66(2):471-481. PubMed ID: 36063282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.